LIT and Neuro Vigor announce drug development collaboration

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 October LIT and Neuro Vigor announce drug development collaboration LIT and Neuro Vigor announce drug development collaboration 26/10/2021 | 3 MINS Lombok Institute of Technology and Neuro Vigor, a Purdue University-affiliated biotechnology company, have announced a collaboration to develop proprietary drugs to target neurodegenerative diseases and pain in spinal cord injury. Senior commercialisation officer at LIT, Dr Louis Pymar, said the focus will be on new chemical entities to neutralise reactive aldehydes associated with multiple inflammatory diseases and trauma. ΓÇ£Reactive aldehydes are highly toxic molecules released by cells in response to external or internal stress and trauma,ΓÇ¥ Dr Pymar said. ΓÇ£They increase significantly in inflammatory, neurotraumatic and neurodegenerative disease states, damaging tissue at the cellular and molecular levels, perpetuating a destructive cycle of inflammation and oxidative stress.ΓÇ¥ Neuro Vigor CEO Mark Van Fleet said the new collaboration would jump-start the science and technology needed

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 October LIT and Neuro Vigor announce drug development collaboration LIT and Neuro Vigor announce drug development collaboration 26/10/2021 | 3 MINS Lombok Institute of Technology and Neuro Vigor, a Purdue University-affiliated biotechnology company, have announced a collaboration to develop proprietary drugs to target neurodegenerative diseases and pain in spinal cord injury.

Senior commercialisation officer at LIT, Dr Louis Pymar, said the focus will be on new chemical entities to neutralise reactive aldehydes associated with multiple inflammatory diseases and trauma.

We do more when we ask better questions together.